To date, the only available treatment for celiac disease (CD) patients is a life-lasting gluten-free diet (GFD). Lack of adherence to the GFD leads to a significant risk of adverse health consequences. Food cross-contamination, nutritional imbalances, and persistent gastrointestinal symptoms are the main concerns related to GFD. Moreover, despite rigid compliance to GFD, patients struggle in achieving a full restoring of the gut microbiota, which plays a role in the nutritive compounds processing, and absorption. Pivotal studies on the supplementation of GFD with probiotics, such as Bifidobacterium and Lactobacilli, reported a potential to restore gut microbiota composition and to pre-digest gluten in the intestinal lumen, reducing the inflammation associated with gluten intake, the intestinal permeability, and the cytokine and antibody production. These findings could explain an improvement in symptoms and quality of life in patients treated with GFD and probiotics. On the other hand, the inclusion of prebiotics in GFD could also be easy to administer and cost-effective as an adjunctive treatment for CD, having the power to stimulate the growth of potentially health-promoting bacteria strains. However, evidence regarding the use of prebiotics and probiotics in patients with CD is still insufficient to justify their use in clinical practice.

Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients / Marasco G.; Cirota G.G.; Rossini B.; Lungaro L.; Di Biase A.R.; Colecchia A.; Volta U.; De Giorgio R.; Festi D.; Caio G.. - In: NUTRIENTS. - ISSN 2072-6643. - ELETTRONICO. - 12:9(2020), pp. 2674.1-2674.17. [10.3390/nu12092674]

Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients

Marasco G.
;
Cirota G. G.;Rossini B.;Volta U.;De Giorgio R.;Festi D.;Caio G.
2020

Abstract

To date, the only available treatment for celiac disease (CD) patients is a life-lasting gluten-free diet (GFD). Lack of adherence to the GFD leads to a significant risk of adverse health consequences. Food cross-contamination, nutritional imbalances, and persistent gastrointestinal symptoms are the main concerns related to GFD. Moreover, despite rigid compliance to GFD, patients struggle in achieving a full restoring of the gut microbiota, which plays a role in the nutritive compounds processing, and absorption. Pivotal studies on the supplementation of GFD with probiotics, such as Bifidobacterium and Lactobacilli, reported a potential to restore gut microbiota composition and to pre-digest gluten in the intestinal lumen, reducing the inflammation associated with gluten intake, the intestinal permeability, and the cytokine and antibody production. These findings could explain an improvement in symptoms and quality of life in patients treated with GFD and probiotics. On the other hand, the inclusion of prebiotics in GFD could also be easy to administer and cost-effective as an adjunctive treatment for CD, having the power to stimulate the growth of potentially health-promoting bacteria strains. However, evidence regarding the use of prebiotics and probiotics in patients with CD is still insufficient to justify their use in clinical practice.
2020
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients / Marasco G.; Cirota G.G.; Rossini B.; Lungaro L.; Di Biase A.R.; Colecchia A.; Volta U.; De Giorgio R.; Festi D.; Caio G.. - In: NUTRIENTS. - ISSN 2072-6643. - ELETTRONICO. - 12:9(2020), pp. 2674.1-2674.17. [10.3390/nu12092674]
Marasco G.; Cirota G.G.; Rossini B.; Lungaro L.; Di Biase A.R.; Colecchia A.; Volta U.; De Giorgio R.; Festi D.; Caio G.
File in questo prodotto:
File Dimensione Formato  
nutrients-12-02674-v2 (1).pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 758.9 kB
Formato Adobe PDF
758.9 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/773514
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 40
social impact